期刊文献+

不同正电子显像剂在前列腺癌中的应用 被引量:1

下载PDF
导出
摘要 前列腺癌是欧美国家男性最常见的恶性肿瘤,在我国的发病率也在逐年上升。^(18)F-FDG是葡萄糖的类似物,能够被糖代谢旺盛的病灶或正常组织摄取,是一种广谱的肿瘤非特异性显像剂,在临床上广泛应用,具有无可替代的地位,被誉为"世纪分子"。但经验表明,其在前列腺癌的早期诊断和分期方面的作用是有限的。
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2016年第3期353-356,共4页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 宜昌市科学研究与开发项目(No.A13301-12) 湖北省科技厅项目(No.2014CFC1036) 湖北省卫计委项目(No.WJ2015MB181)
  • 相关文献

参考文献42

  • 1Gillies R J, Robey I, Gatenby R A. Causes and consequences of increased glucose metabolism of cancers[J]. J Nucl Med, 2008,49 (Suppl 2) 24s-42s.
  • 2Macheda M L,Rogers S,Best J D. Molecular and cellular reg- ulation of glucose transporter(GLUT)proteins in cancer[J]. J Cell Physiol, 2005,202(3) : 654-662.
  • 3Stewart G D, Gray K, Pennington C J, et al. Analysis of hy- poxia-associated gene expression in prostate cancer:lysyl oxi- dase and glucose transporter-1 expression correlate with Glea- son score[J]. Oncol Rep, 2008,20(6) : 1561-1567.
  • 4Effert P, Beniers A J, Tamimi Y, et al. Expression of glucose transporter l(Glut-1)in cell lines and clinical specimens from human prostate adenocarcinoma[J]. Anticancer Res, 2004,24 (5A) : 3057-3063.
  • 5Salminen E, Hogg A, Binns D, et al. Investigations with FDG- PET scanning in prostate cancer show limited value for clini- cal practice[J].Acta Oncol,2002,41(5) 425-429.
  • 6宋吉清,张成琪,陈静,邓凯,姚树展.正电子发射型CT图像融合示踪剂^(11)C-胆碱对前列腺癌诊断价值的初步探讨[J].山东大学学报(医学版),2006,44(2):205-208. 被引量:3
  • 7李昕,王慕文,刘庆伟,朱仁娟,刘理慧,袁宪顺,姚树展,刘松涛.^(11)C-胆碱PET/CT显像在前列腺良恶性病变鉴别诊断中的应用[J].中华核医学杂志,2006,26(6):349-352. 被引量:5
  • 8Liu I J, Zafar M B, Lai Y H, et al. Fluorodeoxyglueose posi- tron emission tomography studies in diagnosis "and staging of clinically organ-confined prostate cancer[J]. Urology, 2001, 57(1):108-111.
  • 9yon Mallek D, Backhaus B, Muller S C, et al. Technical limits of PET/CT with ISF-FDG in prostate eancer[J].Aktuelle Urol,2006,37(3) :218-221.
  • 10Minamimoto R, Uemura H, Sano F, et al. The potential Of FDG-PET/CT for detecting prostate cancer in patients with an elevated serum PSA level[J]. Ann Nucl Meal,2011,25(1) : 21-27.

二级参考文献37

  • 1杨星,张林.PET与CT或MRI异机图像融合的临床应用[J].中华核医学杂志,2005,25(5):290-290. 被引量:5
  • 2柳曦,周乃康,张锦明100853北京,梁朝阳,郑昕,田嘉禾100853北京.^(18)F-FLT在肺癌模型小鼠体内的生物分布及PET显像研究[J].解放军医学杂志,2006,31(10):960-962. 被引量:7
  • 3Sanz G,Rioja J,Zudaire JJ,et al.PET and prostate cancer[J].World J Urol,2004,22(5):351-352.
  • 4Liu I J,Zafar MB,Lai YH,et al.Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancer[J].Urology,2001,57(1):108-111.
  • 5De Jong IJ,Pruim J,Elsinga PH,et al.Visualization of prostate cancer with ^11C-choline:comparison with FDG PET and gadolinium-enhanced MR imaging[J].Eur J Nucl Med,2001,28(11):1 664-1 670.
  • 6De Jong IJ,Pruim J,Elsinga PH,et al.Preoperative staging of pelvic lymphnodes in prostate cancer by ^11C-choline PET[J].J Nucl Med,2003,44(3):331-335.
  • 7Kotzerke J,Prang J,Neumaier B,et al.Experience with carbon-11 choline positron emission tomography in prostate carcinoma[J].Eur J Nucl Med,2000,27(9):1 415-1 419.
  • 8Oyama N,Miller TR,Dehdashti F,et al.^11C-acetate PET imaging of prostate cancer:detection of recurrent disease at PSA relapse[J].J Nucl Med,2003,44(4):549-555.
  • 9Been L B,Suurmeijer A J,Cobben D C,et al.18F-FLT-PET in oncology:current status and opportunities[J].Eur J Nucl Med Mol Imaging,2004,31 (12):1659-1672.
  • 10Shields A F,Grierson J R,Dohmen B M,et al.Imaging proliferation in vivo with 18F-FLT and positron emission tomography[J].Nat Med,1998,4(11):1334-1336.

共引文献28

同被引文献6

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部